curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Sacral Neuromodulation in Patients With Double Incontinence

by palligoelme@gmail.com | Oct 8, 2025 | Clinical Trials

​ Conditions: Double Incontinence; Faecal Incontinence; Urinary Incontinence Interventions: Procedure: Sacral neurostimulation Sponsors: University Hospital Ostrava Not yet recruiting Conditions: Double Incontinence; Faecal Incontinence; Urinary Incontinence...

Immersive Virtual Reality vs Treadmill Exercise Project

by palligoelme@gmail.com | Oct 8, 2025 | Clinical Trials

​ Conditions: Control; Virtual Reality Physical Activity; Treadmill Interventions: Behavioral: VRPA; Behavioral: Treadmill; Behavioral: Control Sponsors: Rowan University Recruiting Conditions: Control; Virtual Reality Physical Activity; Treadmill Interventions:...

Acquired Dyslexia Modeling and Treatment

by palligoelme@gmail.com | Oct 7, 2025 | Clinical Trials

​ Conditions: Stroke; Dyslexia, Acquired Interventions: Behavioral: Phono-Motor Therapy; Behavioral: Semantic Feature Analysis Sponsors: Rutgers, The State University of New Jersey; National Institute on Deafness and Other Communication Disorders (NIDCD) Not yet...

Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area – Post-Market Clinical Follow-up

by palligoelme@gmail.com | Oct 7, 2025 | Clinical Trials

​ Conditions: Bradycardia; Atrioventricular Block; Sinus Node Dysfunction; Bundle-Branch Block Interventions: Device: Pacemaker lead Sponsors: Boston Scientific Corporation Not yet recruiting Conditions: Bradycardia; Atrioventricular Block; Sinus Node Dysfunction;...

Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy

by palligoelme@gmail.com | Oct 7, 2025 | Clinical Trials

​ Conditions: Duchenne Muscular Dystrophy Interventions: Drug: WVE-N531 Sponsors: Wave Life Sciences Ltd. Not yet recruiting Conditions: Duchenne Muscular Dystrophy Interventions: Drug: WVE-N531 Sponsors: Wave Life Sciences Ltd. Not yet...
« Older Entries
Next Entries »

Recent Posts

  • Smart 3: A Multi-Center Phase 2 Trial Of Golcadomide, Glofitamab And Polatuzumab Vedotin (G2P) For Patients With Newly Diagnosed Large B-Cell Lymphoma
  • Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris
  • A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)
  • Effect of Autologous Serum-Soaked Paper Patch vs. Traditional Dry Paper Patch on Tympanic Membrane Perforations
  • Use of cfDNA in Monitoring and Guiding Treatment for Cervical Cancer

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®